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ABSTRACT
RNA structures are increasingly recognized to be of importance during inﬂuenza A virus replication. Here,
we investigated a predicted conserved hairpin in the M gene segment (nt 967-994) within the region of
the vRNA 50 packaging signal. The existence of this RNA structure and its possible role in virus replication
was investigated using a compensatory mutagenesis approach. Mutations were introduced in the hairpin
stem, based on natural variation. Virus replication properties were studied for the mutant viruses with
disrupted and restored RNA structures. Viruses with structure-disrupting mutations had lower virus titers
and a signiﬁcantly reduced median plaque size when compared with the wild-type (WT) virus, while
viruses with structure restoring-mutations replicated comparable to WT. Moreover, virus replication was
also reduced when mutations were introduced in the hairpin loop, suggesting its involvement in RNA
interactions. Northern blot and FACS experiments were performed to study differences in RNA levels as
well as production of M1 and M2 proteins, expressed via alternative splicing. Stem-disruptive mutants
caused lower vRNA and M2 mRNA levels and reduced M2 protein production at early time-points. When
the RNA structure was restored, vRNA, M2 mRNA and M2 protein levels were increased, demonstrating a
compensatory effect. Thus, this study provides evidence for functional importance of the predicted M RNA
structure and suggests its role in splicing regulation.
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Introduction
Inﬂuenza viruses belong to the Orthomyxoviridae and consti-
tute a continuous threat for severe disease outbreaks in humans
and domestic animals.1,2 The viruses have a segmented nega-
tive-sense RNA genome consisting of 8 viral RNA (vRNA)
gene segments, each of which is encapsidated into a virus ribo-
nucleoprotein (vRNP) complex. A vRNP contains multiple
viral nucleoprotein (NP) molecules and the polymerase com-
plex (PB2, PB1 and PA).3,4 Similar to other viral RNA genomes,
the inﬂuenza A virus genome is expected to contain structured
cis-acting elements which regulate genome functioning in viri-
ons and infected cells.5 In particular, inﬂuenza virus RNA
structures are mostly suggested to be involved in mRNA splic-
ing and vRNA packaging into virions.6-11 The locations con-
taining the minimal packaging signals, necessary to incorporate
the 8 different vRNPs into virus particles, were shown to
involve the 50- and 30- untranslated regions (UTR) and extend
into the coding parts of each gene segment (reviewed in4,11).
Noda et al.12 demonstrated a highly ordered (7C1) organiza-
tion of the vRNPs. Further studies revealed complex interseg-
ment RNA-RNA interaction networks, that may vary between
different virus subtypes10,13-15 and a possible role for the inter-
actions of small vRNA hairpins (“kissing loops”) on the
vRNPs.13 In segment 5 (NP), a conserved RNA pseudoknot in
the region spanning the 50 packaging signal was shown to affect
virus replication.16 Conserved hairpins were predicted in the
packaging signal regions of segment 4 (HA), although nucleo-
tide covariations in these hairpins exhibited relatively weak
constraints and disruption of the structures did not result in
noticeable effects on virus replication.17
In the 2 gene segments with alternatively spliced pre-
mRNAs, M and NS, the regions in the vicinity of splice sites are
able to fold into alternative RNA structures that can regulate
splicing efﬁciency.7,8,18,19 The M gene segment produces several
types of mRNA: unspliced M1 mRNA and splice variants M2,
M3 and M4 mRNA (Fig. 1A).20-22 M3 mRNA does not encode
any protein, but is involved in regulating the switch to M2
mRNA production early in infection and is thereby delaying
M2 protein production compared with M1.23 The ratio between
M2 and M1 mRNA was shown to increase during infection,
although M2 mRNA splicing is regulated in such a way that it
remains a small proportion compared with M1 mRNA.24
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Differences in the M2/M1 mRNA ratio were observed between
different virus strains and splicing efﬁciency therefore seems to
be strain speciﬁc.18 M4 mRNA encodes an M2 variant (M42)
with a different N-terminus that can be expressed by a minority
of inﬂuenza A virus strains and can complement M2 protein
function through the formation of an ion channel.22
The region containing the 50 packaging signals in segment 7
(M) was suggested to contain a stable hairpin (at nucleotides
967-994), predicted by thermodynamics-based folding algo-
rithms, and is conserved in all inﬂuenza A virus strains
(Fig. 1A, B).5,25 This hairpin was also detected by in vitro struc-
ture probing of protein-free M vRNA.26 Several studies have
investigated the region that spans this predicted M RNA struc-
ture. First, Hutchinson et al. introduced synonymous mutations
in the M2 codon of amino acids 90-92 (nucleotide positions
983, 986 and 989, located in the loop and stem of the hairpin).
This virus showed reduced virus replication in a plaque assay
as a consequence of a packaging defect.27 Second, Ozawa et al.
determined the minimal packaging regions of M and further
investigated the 50 end of the packaging region. It was shown
that nucleotide composition was more important than amino
acid sequence.28 Third, Kobayashi et al. introduced a combina-
tion of 3 synonymous mutations to disrupt the predicted M
RNA structure and a 5-fold reduction in virus titer was
observed.29 Together, these data indicate that the 50 terminal
region of the M gene segment, comprising the RNA structure
as previously predicted,5,25 affects virus replication and plays a
role in the inﬂuenza virus packaging mechanism.
Here, we studied the functioning of this RNA structure
using a compensatory mutagenesis strategy. The results dem-
onstrated that hairpin disruptive mutations had a negative
effect on virus replication, which can be reverted by structure-
restoring mutations. Surprisingly our data indicate involvement
of the RNA structure in regulating M mRNA splicing, despite
its location in the packaging signal region at a distance more
than 200 nucleotides away from the end of the M gene intron
(Fig. 1A).
Results
Strategy of the stem compensatory mutagenesis
The best way to obtain convincing experimental evidence of
functional importance of a double-stranded RNA structure is
to demonstrate compensatory effects in mutants containing
double substitutions at the paired nucleotide positions. In case
Figure 1. (A) Schematic overview of the main functional sites in the M gene segment. The regions of minimal packaging signals (PS) in the vRNA (negative-sense) are
according to Ozawa et al.28 The base numbering starts at the vRNA 30-end. The unspliced M1 RNA and 3 splice variants produced by alternative 50 splice sites (5ss) contain
5 potential open reading frames,22 shown here by thick bars. M1 and M2 are important viral proteins, while M42 is probably expressed in a minority of strains; proteins M3
and M4 were never detected. The location of hairpin 967-994 is shown schematically. (B) Natural (co)variations in the 967-994 hairpin stem in human H1N1 viruses. The
years of isolation of strains with these variations are indicated. A/NY/649/95 denotes A/New York/649/1995 (H1N1), a strain with unique 972/989 covariation. (C) Muta-
tions that were introduced into the hairpin. Non-synonymous substitutions are marked with asterisks, corresponding amino acid changes in M2 protein are indicated as
well.
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the RNA structure is located in the protein-coding RNA region,
the introduced mutations should minimally affect the functions
of the encoded protein(s) to avoid protein function modiﬁca-
tions and misinterpretation of the data. The hairpin at position
967-994 is located downstream of the M1 stop-codon. How-
ever, each of the base pairs in the stem involves at least one
nucleotide at the ﬁrst or second position in M2 codons, making
it impossible to design compensatory mutants in this structure
with only silent substitutions. Therefore it was decided to
explore the natural variation in the stem nucleotides of the
hairpin to select mutations yielding functional M2 protein. In
particular, variation observed in the human H1N1 strains was
explored, as the experimental system used was based on the A/
PR/8/34 (H1N1) reverse genetics system.
First, substitutions that characterize the previously identiﬁed
natural covariation at base pair 970-9915,25 (Fig. 1B) were
selected. At this position there is a CG pair in the majority of
human strains (including A/PR/8/34), in contrast to UA in some
of the early human H1N1 viruses and in avian strains. In addi-
tion, the G-C/U-A covariation at position 972-989, observed in
one of the human H1N1 strains (A/New York/649/1995
(H1N1); accession CY011281), was selected. It involved 2 trans-
versions (Fig. 1), one silent, of nucleotides that are invariant in
all other M segments from human strains available in the data-
base (in total 9163 sequences), apparently indicating the impor-
tance of pairing at this position. Apart from these 2 natural
covariations, it was noted that several human strains of different
subtypes, including some human H1N1 viruses, have the G969A
substitution (Ala86Thr in M2), which is easy to combine in
experiments with a silent C992U substitution of the nucleotide,
paired in the suggested structure model. Thus, in total 3 pairs of
point mutations that can be used for compensatory mutagenesis
of the A/PR/8/34 M gene segment were selected (Fig. 1C). To
enhance the structure-destabilizing effects of substitutions, they
were combined in 2 sets (SL1-SR1-SLR1 and SL2-SR2-SLR2),
each dealing with disruption and reversion of 2 base pairs. The
mutations were introduced in the stem (S) of the predicted RNA
structure and were located either on the left side (L), right side
(R) or both sides (LR). Thus SLR1 included all mutations of SL1
and SR1, and SLR2 included all mutations of SL2 and SR2. In
this way, SL1, SR1, SL2 and SR2 mutants should destabilize hair-
pins, each with 2 mismatches, whereas the perfect RNA duplex
should be restored in SLR1 and SLR2 despite the 4 nucleotide
substitutions compared with the WT sequence.
Stem mutant viruses and the effect on viral replication
Mutations were introduced into the stem of the predicted RNA
structure as described above (Fig. 1C and 2A). Mutant viruses,
including an A/PR/8/34 WT control, were produced by reverse
genetics and the M gene segment of the recombinant viruses
was sequenced. All mutants contained the desired mutations and
no additional co-mutations were detected. Subsequently, virus
titers of the 2 sets of mutant viruses (SL1-SR1-SLR1 and SL2-
SR2-SLR2) were determined (Fig. 2A). Recombinant viruses with
mutations at one side of the stem (SL1, SR1, SL2 and SR2) had
lower virus titers (107.3, 107.3, 107.1 and 107.1 TCID50/ml, respec-
tively) than the WT virus (108.4). However, recombinant viruses
that contained mutations at both sides of the stem (SLR1 and
SLR2), predicted to re-stabilize the RNA structure, had virus
titers of 108.3 and 108.1 respectively, which was similar to the
WT virus (108.4). When mutant viruses SL1, SR1, SLR1 and the
WT virus were passaged 6 times in MDCK cells, at each passage,
a 1-2 log lower virus titer was observed between disruptive
mutants SL1/SR1 and the compensatory mutant SLR1 and WT
virus. At each passage the MA gene segment was sequenced to
conﬁrm the presence of the desired mutations and absence of
undesired co-mutations (data not shown).
Next, plaque assays were performed to determine virus rep-
lication efﬁciency in a more sensitive way with larger plaque
sizes corresponding to more efﬁcient virus replication. Viruses
containing the SL1 and SR1 mutations showed smaller median
plaque sizes (1.37 and 1.28 mm respectively) when compared
with the WT (1.79 mm) and SLR1 (1.87 mm) virus (Fig. 2B).
This was statistically signiﬁcant (p < 0.001) for the SL1 and
SR1 mutant compared with the WT virus. The second set of
mutations (SL2-SR2-SLR2) showed a similar pattern (Fig. 2B),
with median plaque sizes of 1.17 and 1.11 mm for mutant SL2
and SR2, respectively when compared with WT (1.79 mm) and
SLR2 (1.60 mm), which was statistically signiﬁcant (p < 0.001)
compared with the WT virus. Together, these data provide
experimental support for the existence and functional impor-
tance of the predicted RNA hairpin structure, shown by the
compensatory effect of the stabilizing mutants (SLR1 and
SLR2) on virus replication.
Loop mutant viruses and the effect on viral replication
Next, recombinant viruses containing 4 silent mutations in the
hairpin loop (L) at position 977, 980, 983 and 986 (quadruple
mutant; LQ) of the predicted RNA structure were produced to
investigate if the loop may be involved in RNA interactions
(e.g. via “kissing loops”) that affect virus replication (Fig. 1C
and 2A). It should be noted that although nucleotide 986 is sug-
gested to be paired in the M mRNA hairpin stem (Fig. 1B), it is
likely to be located in the larger loop of the vRNA (negative
sense) counterpart hairpin5,26 due to the 986–975 AC mismatch
that also makes the formation of the isolated neighboring base
pair 985–976 unlikely. At nucleotide position 980 2 nucleotide
changes were possible that resulted in silent mutations; conse-
quently both U980A (LQ1) and U980C (LQ2) mutations were
introduced. Loop mutants LQ1 and LQ2 had a virus titer of
107.5 and 108.0 respectively, compared with 108.4 for the WT
virus (Fig. 2A). Both LQ1 and LQ2 mutant viruses were tested
in a plaque assay (Fig. 2B) and showed a reduced median pla-
que size (1.19 mm for LQ1 and 1.17 mm for LQ2) when com-
pared with the WT virus (1.79 mm), which was statistically
signiﬁcant (p < 0.001). Subsequently, the inﬂuence of different
mutations in the loop were determined by introducing muta-
tions from the left (nt position 977) to the right (nt position
986) side of the hairpin loop. Single (LS977), double (LD1/LD2),
triple (LT1/LT2) and quadruple (LQ1/LQ2) mutant viruses,
where 1 represents an A at position 980 and 2 a C at this posi-
tion, were produced. Subsequently, the virus titer was deter-
mined (Fig. 2A). In general, the different loop mutants had
virus titers that were similar to the WT virus (108.4), except
LT2 (107.1) and LQ1 (107.5). Next, these mutant viruses were
tested in a plaque assay (Fig. 2C). For the single loop mutant
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(LS977) a small decrease in median plaque size (1.47 mm) was
observed compared with the WT virus (1.75 mm), which was
statistically signiﬁcant (p < 0.05). Both double mutants (LD1
and LD2) showed a decreased median plaque size (1.43 mm
and 1.64 mm respectively) compared with the WT (1.75 mm);
this difference was only statistically signiﬁcant (p < 0.05) for
mutant LD1. Both triple mutants (LT1 and LT2) showed a
small decrease in median plaque size (1.48 mm and 1.56 mm
respectively) compared with the WT (1.75 mm), although this
difference was not statistically signiﬁcant. Overall, the biggest
and most signiﬁcant (p < 0.001) decrease in median plaque
size was observed for the quadruple mutants (1.20 mm and
1.34 mm compared with 1.75 mm for the WT). Therefore, a
recombinant virus containing only the U986C (LS986) mutation
was produced and no difference in virus titer (Fig. 2A) was
observed. In the plaque assay (Fig. 2C) the mutant had even a
slightly higher (0.99 mm) median plaque size compared with
the WT (0.88 mm), but this difference was not statistically sig-
niﬁcant. Therefore, the isolated mutation at nucleotide position
986 was not responsible for the decrease in median plaque size,
observed in the quadruple mutants.
Functional effects of stem-loop mutations
To gain more insight into the possible function of the M RNA
structure, northern blot assays were performed to determine
Figure 2. (A) Overview of the mutations that were introduced into the M gene segment of the 967-994 RNA structure showing the expected outcome and the effect on
virus replication. (B) Investigation of the effect of the stem (SL1, SR1, SLR1, SL2, SR2 and SLR2) and quadruple loop mutants (LQ1 and LQ2) in a plaque assay compared
with the WT control. The plaque radius (in mm) is shown. Statistical signiﬁcance was determined by using the Kruskal-Wallis and Dunn’s multiple comparison test and is
depicted by one (p < 0.05) or 2 (p < 0.01) asterisks. The red bars represent the median. (C) The effect of single, double, triple and quadruple loop mutants were com-
pared in a plaque assay. The x-axis was disconnected to identify a separately performed plaque assay where mutant SL986 was compared with the WT virus. Statistical sig-
niﬁcance was determined by using the Kruskal-Wallis and Dunn’s multiple comparison test or the Mann-Whitney t-test. The red bars represent the median.
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RNA levels. Mutants SL1, SR1, SLR1 and LQ1 were selected (as
a representative set), together with WT virus, a negative control
(NC) consisting of RNA extracted from mock infected MDCK
cells and a positive control consisting of RNA extracted from
293T cells transfected with expression plasmids. Total RNA
was extracted from MDCK cells that were inoculated at a mul-
tiplicity of infection (MOI) of 1 with the selected set of viruses
and run on a 1% agarose gel. After Northern blot, the mem-
branes were hybridized with probes against (-)RNA, (C)RNA
and M2 mRNA (Fig. 3). To determine the volume (intensity) of
the bands the area equivalent to the widest band of the blot was
selected for analyses. The volume (intensity) of each band was
then compared with the WT and the relative quantity (RQ)
calculated.
Lower vRNA levels were detected for all mutant viruses
when compared with the WT virus (Fig. 3A). The reduction in
RQ vRNA levels were more pronounced for SL1 (0.67) and SR1
(0.51) than for SLR1 (0.77) and LQ1 (0.76). The vRNA levels
correlated with the virus titers, as both SL1 and SR1 showed a
reduction of »1 log in virus titer compared with the WT virus.
Mutant SLR1 replicated similar to the WT virus in a plaque
assay, but the vRNA level was slightly reduced compared with
that of the WT virus.
The Northern blot detecting (C)RNA is shown in Fig. 3B.
Here, higher RQ (C)RNA levels were detected for the SL1
(1.38), SR1 (1.36) and LQ1 (1.56) mutants compared with
SLR1 (1.05) and WT (1.0). Both cRNA and unspliced M1
mRNA are detected by the (C)RNA probe and this will result
in bands of approximately the same size. Therefore, poly AC
mRNA was isolated from total RNA and this was subsequently
used in a Northern blot experiment (Fig. 3C) with the (C)RNA
probe to measure M1 mRNA levels for the stem mutants. Simi-
lar RQ levels of M1 mRNA were detected for SL1 (0.85), SR1
(0.93), SLR1 (0.81) compared with the WT (1.0).
The RQ M2 mRNA levels were lower (Fig. 3D) for the struc-
ture-disrupting mutants SL1 (0.65) and SR1 (0.64) as compared
Figure 3. Northern blot experiments. Total RNA was extracted from MDCK cells inoculated with SL1, SR1, SLR1, WT, LQ1 and mock (NC). As a positive control for (-)RNA a
unidirectional pSP72-PhuTmu plasmid containing the M gene segment was transfected into 293T cells, which produces only negative sense vRNA. Additionally, pCAGGS-
M1 (M1) and pCAGGS-M2 (M2) plasmids were transfected into 293T cells to serve as positive mRNA controls. Approximately 40 hours after transfection, total RNA was
extracted and used to produce Northern blot. Arrow heads indicate the region of interest. A representative blot of 3 experiments is shown for (-)RNA (A), (C)RNA (B) and
M2 mRNA (D). The 2 bands in panel D correspond to unspliced M1 and spliced (M2) mRNA. (C) Total RNA from SL1, SR1, SLR1 and WT was used for polyA puriﬁcation to
isolate mRNA and this was used in a Northern blot with the (C)RNA probe.
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with WT (1.0). A compensatory effect for structure-restoring
mutant SLR1 was observed with near-WT RQ levels of 1.08. In
contrast, the quadruple loop mutant LQ1 resulted in higher RQ
M2 mRNA levels (1.25) compared with the WT virus. In the
M2 mRNA Northern blot a second (larger) band was observed,
as the region of the M2 mRNA probe is also present in cRNA
and unspliced M1 mRNA. Both the structure-disrupting and
the loop mutants showed higher RQ (C)RNA levels (1.14 for
SL1, 1.27 for SR1 and 1.40 for LQ1), although a larger increase
was observed with the other (C)RNA probe (1.38 for SL1, 1.36
for SR1 and 1.56 for LQ1 (Fig. 3B). Structure-restoring mutant
SLR1 showed a minor increase in RQ level with both probes of
1.05 with the (C)RNA probe and 1.13 with the M2 mRNA
probe. A similar (C)RNA pattern was observed in 3 indepen-
dent experiments with both probes. Based on these data a
slightly higher level of cRNA in the structure disrupting
mutants is suggested, as well as lower vRNA and M2 mRNA
levels.
Detection of MA protein levels
As the Northern blot data showed a relatively strong reduction
in M2 mRNA production for stem disrupting mutants, the
kinetics of M1 and M2 protein levels at early time-points were
studied by FACS analysis. MDCK cells were inoculated at a
MOI of 3 with mutant (SL1, SR1, SLR1, LQ1) and WT viruses
and samples were collected with a 30 minute time interval.
Cells were harvested and stained for NP and the M1 or M2 pro-
tein. Within the virus infected cell population (NP positive
cells), the percentage M1 or M2 positive cells and the mean
ﬂuorescence (MF) levels of M1 or M2 were determined. The
percentage of M positive cells was multiplied by the MF to cal-
culate M1 and M2 protein levels. Similar results were obtained
in 3 independent experiments with a slightly different experi-
mental setup. A representative experiment is shown in Fig. 4.
Similar levels of total M1 protein were observed for all
mutant viruses (Fig. 4A). For M2, negligible levels of total M2
protein were observed until 4 hours post-inoculation (Fig. 4B).
From 4 hours onwards M2 production increased, albeit at a
slower rate for the stem-disruptive mutants SL1 and SR1. The
structure-restoring mutant SLR1 resembled the pattern of the
WT although the values at the different time-points were
slightly lower. The loop mutant LQ1 showed an intermediate
pattern at 4 .5 hours but resembled the pattern of the structure
disrupting mutants at 5 and 5.5 hours. Overall, the patterns of
total protein corresponded to the Northern blot data, except
for loop mutant LQ1, where a higher level of M2 protein pro-
duction was expected.
Together, these data showed that the structure disruptive
mutations in the stem (SL1 and SR1) negatively inﬂuenced
virus replication, produced similar amounts of M1 mRNA and
less M2 mRNA and vRNA. Additionally, a consistent pattern
for mRNA and protein levels was observed. The structure-
restoring mutant (SLR1) replicated like the WT virus and had
M1/M2 mRNA and protein levels that were comparable to the
WT, although still a small reduction in vRNA level was
observed.
Discussion
Previous identiﬁcation of RNA structures in the inﬂuenza virus
genome13,16,17,26,29-31 and the hypotheses that vRNA-vRNA
interactions play a role in the enigmatic inﬂuenza A virus pack-
aging mechanism9,32,33 make them an interesting subject for
experimental studies. Here, we studied a previously predicted
RNA hairpin structure in the packaging signal region of the M
gene segment (nt 967-994)5,25,29 using a compensatory muta-
genesis strategy with A/PR/8/34 inﬂuenza A virus to determine
the effect of RNA folding on virus replication. The mutant
viruses were further used to study possible functions of the
hairpin structure during virus replication by determining dif-
ferences in RNA and protein levels.
In several previous studies mutations were introduced into
the region spanning this hairpin27,28 or a mutagenesis approach
was based upon the predicted RNA hairpin structure29; in all
studies a (small) effect on virus replication was observed and
the 50-terminal region in the M gene segment (983–1027) was
shown to play a role in packaging.27,28 Based on these data and
the location of the hairpin within the packaging region28 a role
in inﬂuenza virus genome packaging was therefore implied.
The hairpin structure may be involved in packaging by inter-
acting with another gene segment based on loop-loop “kissing”
complex contacts between gene segments.9,13 A pronounced
inﬂuence of the hairpin on pre-mRNA splicing was less
expected, bearing in mind that the distance to the intron of the
M gene segment (52–739) is more than 200 nucleotides (Fig. 1).
Figure 4. Time-lapse FACS experiment to determine M1 and M2 protein levels in inﬂuenza A virus infected MDCK cells. MDCK cells were inoculated with mutant (SL1,
SR1, SLR1, LQ1) and WT viruses at MOI 3. From 21/2 hours post-inoculation onwards, cells were harvested at a 30 minute time interval and used to stain for NP protein as
a marker for virus infected cells and, simultaneously, for either M1 or M2 protein. Data are shown from the moment of ﬁrst detection (31/2) to 5
1/2 hours post-inoculation
to emphasize the differences at early time-points. (A) M1 protein levels within the virus infected (NP-positive) population and (B) M2 protein levels are shown. M1 and
M2 protein levels were calculated by multiplying MF levels with the percentage of M1 or M2 infected cells.
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The compensatory mutagenesis study described here,
revealed that introduction of mutations, based on natural varia-
tion, at either side of the stem in the hairpin structure resulted
in decreased viral replication both in virus titration and plaque
assay experiments. This is also consistent with the reduced
infectivity of mutants containing stem mismatches as studied
by Kobayashi et al.29 Introduction of silent mutations in the
loop of the predicted hairpin structure also resulted in reduced
plaque sizes, with the largest effect observed with quadruple
mutant LQ1. The fact that virus replication was affected by
mutations in the loop supports the hypotheses that the loop of
the hairpin structure is involved in a functional interaction
(e.g., with another M gene segment domain or another mole-
cule). Unfortunately, without knowing the interacting partner,
further experimental studies are difﬁcult.
In Northern blot experiments, disruptive stem mutants (SR1
and SL1) showed reduced levels of vRNA and M2 mRNA com-
pared with WT. Differences in M1 mRNA levels were relatively
small. M2 mRNA levels were restored completely and vRNA
levels partly in compensatory mutant virus SLR1. For loop
mutant (LQ1) lower vRNA and higher M2 mRNA levels than
the WT were observed. It should be noted that the different
splice events in the M gene segment result in overlapping
mRNA regions for M2, M3 and M4 (Fig. 1A) which might
potentially complicate the interpretation of the Northern blot
data.22 However, cross-reactivity with M3 and M4 mRNA is
not expected as Shih et al.23 showed that M3 mRNA is only
produced early in infection and Wise et al.22 detected no M3
and M4 mRNA in cells infected with A/PR/8/34 at 6 hours
post-inoculation. A FACS time-course experiment demon-
strated that M2 protein was produced at a slower rate for the
structure-disrupting mutants (SL1 and SR1), the compensatory
mutant SLR1 showed a pattern that resembled that of the WT.
M1 protein production was similar for all the mutants and WT
virus, and this pattern was consistent with the Northern blot
data. However, after 5.5 hours post-inoculation these differen-
ces became smaller and thus no difference in M2 protein levels
were observed as with the Northern blot at later time-points.
These data suggest that M2 mRNA production is slightly
delayed (this may be caused by a delayed switch from M3 to
M2 mRNA23) as the differences in M2 protein production were
only detectable at early time-points.
Interestingly, mutant virus M2 H90-V92 (amino acid posi-
tion 90-92), described by Hutchinson et al.27 contained a com-
bination of our loop mutations U983C and U986C, together
with substitution C989A in the stem. This M2 mutant resulted
in lower virus titers, smaller plaques and a »5-fold reduction
in vRNA accumulation between 8 and 22 hours and was there-
fore suggested to cause a defect in packaging, with possible
pleiotropic effects. However, no effect on mRNA levels was
detected. On the other hand, our quadruple loop mutant (con-
taining U983C and U986C) showed equal amounts of M2
mRNA and stem mutants SL1 and SR1 (containing C989A)
both had reduced M2 mRNA levels. The differences may be
due to the different combination of mutations that were tested.
Our results indicate that the predicted RNA structure is
involved in splicing. This splicing regulation can be realized by
long-distance interactions with M mRNA splice site regions
that change their structures and/or accessibility to the splicing
machinery (Fig. 5), or mediated by binding to other splicing
factors. In NS mRNA, a 85-nucleotide-long cis-acting region,
located 147 nucleotides downstream of the NS intron, was
shown to inhibit splicing.34 Although here the opposite effect is
observed, the similarity in the location of M and NS exonic reg-
ulatory elements is intriguing. It is also possible to suggest that
the folding of the M 967-994 hairpin operates as a splicing
enhancer by simply preventing its sequence to exert an inhibi-
tory effect. On the other hand, the splicing regulation systems
of NS and M mRNAs differ considerably, in particular, M1
mRNA is spliced in nuclear speckles while NS1 mRNA is not.35
Splicing and nuclear export of M1 mRNA is characterized by a
complex regulation with the presence of alternative 50 splice
sites and several splicing factors.22,35-38
The restoration of viral ﬁtness in the compensatory mutants
showed that changes in both hairpin nucleotide sequence and
encoded amino acids in this region can be tolerated more than
distortions of the helical stem structure. Furthermore, in addi-
tion to the 2 covariations in H1N1 strains at position 970/991
and 972/989 described above (Fig. 1B), the covariations of the
971/990 pair between them were also identiﬁed in the GenBank
sequences of M segments from viruses of other subtypes: in 3
American avian strains of 1994 and 1995 (H7N3, H7N2 and
H11N2) and in the group of 29 avian H5N1 viruses of the
Egypt 2009/2010 outbreak. Strong structural constraints in the
M gene segment 967-994 hairpin are consistent with the multi-
functional role, suggested here, in virus replication.
Here, we showed that mutants with a destabilized hairpin
stem produced less vRNA, spliced M2 mRNA and affected
virus replication. When mutations were introduced on both
sides of the hairpin structure, the replication defect was
restored, together with a complete restoration of wild type M2
splice levels and partial restoration of vRNA synthesis. Our
data are consistent with a role of this hairpin in inﬂuenza virus
genome packaging and suggest its involvement in regulating
the M splicing mechanism.
Materials and methods
Cells
293T cells were cultured in DMEM (Lonza, Breda, the
Netherlands) supplemented with 10% FCS, 100 IU/ml penicillin
(Lonza), 100 mg/ml streptomycin (Lonza), 2 mM glutamine
(Lonza), 1 mM sodiumpyruvate (Gibco, Leusden, the
Netherlands) and non-essential amino acids (Lonza). Madin-
Darby Canine Kidney (MDCK) cells were cultured in EMEM
(Lonza) supplemented with 10% FCS, 100 IU/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine, 1,5 mg/ml sodiumbi-
carbonate (Lonza), 10 mM hepes and non-essential amino acids.
Plasmids and mutagenesis
Plasmids containing the gene segments of A/PR/8/34 were
described previously.39 The M gene segment was used to
introduce mutations into the region of the predicted RNA
structure using the Quickchange Multi Site Directed Muta-
genesis kit (Agilent, Amstelveen, the Netherlands) according
to the manufacturer’s instructions. The presence of the
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desired mutations in the plasmids were conﬁrmed using a
3130XL genetic analyzer (Applied Biosystems, Bleiswijk, the
Netherlands). All primer sequences are available upon
request. The A/PR/8/34 M unidirectional pSP72-PhuTmu
plasmid was described previously.39 The coding regions of
A/PR/8/34 M1 and M2 were cloned into the EcoRI-XhoI
restriction sites of pCAGGS, the pCAGGS plasmid was
kindly provided by Dr. A. Garcia-Sastre (Icahn School of
Medicine, New York, USA).
Production of recombinant virus
Recombinant viruses were produced as described previously.16
In brief, 293T cells were transfected with 5 mg of plasmid DNA
containing the desired M mutant and 5 mg of the remaining A/
PR/8/34 bidirectional plasmids each. The 293T supernatant
was harvested and used to inoculate MDCK cells. The MDCK
supernatant containing recombinant virus was further used to
assess the 50 percent tissue culture infectious dose (TCID50) in
virus stocks as described previously.16
Plaque assay
The plaque assay was performed as described previously.16,40
Data were analyzed using ImageQuant TL colony counting
software version 8.1 (GE Healthcare, Life sciences, Eindhoven,
the Netherlands). Plaque size was plotted as the plaque radius
(in mm) and displayed using Graphpad Prism 4 (Graphpad
Software, La Jolla, USA).
Northern blot
Unidirectional M, pCAGGS-M1 and pCAGGS-M2 plasmids
were transfected in 293T cells to serve as positive controls in
the Northern blot experiments. Samples for Northern blot anal-
ysis were prepared by inoculating MDCK cells with the desired
mutant viruses at MOI 1. One hour after inoculation the cells
were washed with PBS once and fresh infection medium was
added. Approximately 40 hours after transfection or 8 hours
after inoculation, cells were washed with PBS once. Trizol
(Invitrogen, Life Technologies, Bleiswijk, the Netherlands) was
added to the cells and RNA was isolated according to the
Figure 5. Putative functional interactions of the 967-994 hairpin of the M gene segment. The interactions of the 967-994 hairpin with some of the structures suggested to
fold in the splice site regions30,42-45 may regulate RNA splicing. An equilibrium between alternative structures in the 30 splice site region (707-768) was previously sug-
gested.42,45 The apical part of the stem loop domain 130-217 may also undergo a conformational transition, the structure shown here is more likely for the A/PR/8/34 M
segment sequence.44 The hairpin and/or its complement in the negative-sense vRNA may be also involved in other interactions and functions such as RNA packaging. All
known M RNA splice sites are indicated here, but the A/PR/8/34 M4 50 splice site is not expected to be used, because its sequence does not correspond to the optimal
consensus.22 Thus M42 protein expression should not occur in this strain, while expression of M3 and M4 ORFs in inﬂuenza A viruses is purely hypothetical.22,37 5ss, 50
splice site; 3ss, 30 splice site.
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manufacturer’s instructions. Total RNA (90 mg) was also used
to extract mRNA using the MicroPoly(A)Purist kit (Ambion,
Life Technologies, Bleiswijk, the Netherlands) according to the
instructions of the manufacturer. Samples for the Northern
blot were prepared by mixing RNA (7.5 mg) and RNA millen-
nium marker (2 ml; Ambion) 1:1 with Glyoxal loading dye
(Ambion), this was then incubated at 50 C for 30 minutes.
Samples were loaded on a 1% agarose gel prepared with 1x Gel/
Running buffer (Ambion) and run at 68 Volts. RNA was subse-
quently transferred from the agarose gel to a positively charged
nylon membrane (Brightstar-Plus, Ambion) by downward
transfer for »31/2 hours. The RNA was then cross-linked for 15
minutes at 80 C and the blot was pre-hybridized in 10 ml of
ULTRAhyb (Ambion) buffer for 30 minutes at 68 C using a
hybridization (roller) oven (GE Healthcare, Eindhoven, the
Netherlands). Biotinylated probes to detect positive sense RNA
((C)RNA), M2 mRNA and negative sense vRNA ((-)RNA)
were generated using the MAXIscript Kit (Ambion) according
to the manufacturer’s instructions. PCR products that con-
tained a T7 promoter sequence were used as a template. The
(C)RNA probe was located in the M1 region (nucleotide 232-
632), the M2 mRNA probe was located at the 30 proximal
region of M2 (nucleotide 787-969) and the (-)RNA probe con-
tained the M1/M2 overlapping “splice acceptor” region (nucle-
otide 501-800). Northern blotting was performed using the
NorthernMax-Gly kit (Ambion) according to the manufac-
turer’s instructions. After pre-hybridization, the probe was
added to a ﬁnal concentration of 0.1 nM and hybridized at
68 C overnight. The next day, the blot was washed once with
low stringency wash solution (2x SSC, 0.1% SDS) for 10
minutes at room temperature, followed by 2 washes with high
stringency wash solution (0.1X SSC, 0.1% SDS) for 15 minutes
at 68 C. The biotin signal was detected using the AP chemilu-
minescent blotting kit (KPL, Gaithersburg, USA) according to
the manufacturer’s instructions. The blot was imaged with a
Chemidoc MP imaging system (BioRad, Veenendaal, the
Netherlands) and analyzed using Image Lab software (version
4.0.1, BioRad).
M1 and M2 protein expression in infected cells
MDCK cells were inoculated with the desired mutant viruses at
a MOI of 3 and incubated at 37 C and 5% CO2 for the appro-
priate time. From 21/2 hours onwards a plate containing the set
of desired viruses was removed from the incubator with a 30
minute time interval. The cells were washed with PBS once and
500 ml of 0.05% trypsin-EDTA (Life Technologies, Bleiswijk,
the Netherlands) was added to the cells and incubated at 37 C.
After 5-10 minutes of incubation, the cells were transferred to a
tube containing PBS-1% FCS and centrifuged for 5 minutes at
1500 rpm. Next, the cells were resuspended in 400 ml PBS-1%
FCS and 2 £ 200 ml (for M1 and M2 staining) was transferred
to a 96-well v-bottom plate (Corning life sciences, Amsterdam,
the Netherlands). The plate was incubated at 4 C until all sam-
ples were harvested. At the end of the day, the plate containing
all the samples was centrifuged for 5 minutes at 1500 rpm and
4 C. The cells were resuspended in 100 ml of cytoﬁx/cytoperm
(BD Biosciences, Breda, the Netherlands) and incubated on ice
for 20 minutes. Subsequently, the plate was centrifuged for 5
minutes at 500 £ g and 4 C and the cells were resuspended in
100 ml perm-wash buffer (BD Biosciences). The plates were
stored overnight at 4 C in the dark. The next day, the cells
were stained for NP and M1 or NP and M2 essentially as
described previously.41 Primary antibodies against NP (IgG2A,
Clone Hb65; ATCC), M1 (IgG1, Clone Hb64; ATCC) and a
monoclonal mouse antibody against M2 (IgG1, clone 14C2;
Abcam, Cambridge, UK) were used at a 1/100 dilution in
perm/wash. Secondary goat-anti-mouse antibody against IgG1
(APC; Thermo Fisher Scientiﬁc, Bleiswijk, the Netherlands)
and goat-anti-mouse antibody against IgG2A (Alexa Fluor 488;
Invitrogen, Life Technologies) were diluted 1:100 in perm/
wash. The cells were resuspended in PBS and the percentage of
M1 and M2 positive cells, as well as the M1 and M2 mean ﬂuo-
rescence were determined within the NP positive population by
FACS on a FACS Canto (BD Biosciences, Breda, the Nether-
lands). The data were analyzed using FACSDiva software (BD
Biosciences).
Statistics
Statistical signiﬁcance of the plaque assay data was performed
using the nonparametric Kruskal-Wallis test with a Dunns
post-test, when more than 2 groups were compared. A p-value
<0.05 was considered to be signiﬁcant. Statistical signiﬁcance
was compared with the median plaque size of the wild-type
(WT) virus. If 2 groups were compared, the nonparametric
Mann-Whitney t-test was performed where p < 0.05 was con-
sidered signiﬁcant. All statistical analyses were performed using
GraphPad Prism 4.02 for Windows (GraphPad Software, San
Diego, CA, USA).
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